PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the antitumor activity of PPX in combination with
temozolomide and radiation for patients with newly diagnosed brain tumors.
Phase:
Phase 2
Details
Lead Sponsor:
howard safran
Collaborators:
Maine Medical Center Research Institute MaineHealth Rhode Island Hospital